| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.22 | $66.60 (0%) | 🛒 Add to cart |
| 60 | $1.80 | $133.20 $107.97 (19%) | 🛒 Add to cart |
| 90 | $1.65 | $199.80 $148.33 (26%) | 🛒 Add to cart |
| 120 | $1.58 | $266.39 $189.70 (29%) | 🛒 Add to cart |
| 180 | $1.51 | $399.59 $271.44 (32%) | 🛒 Add to cart |
| 270 | $1.46
Best per pill | $599.39 $393.54 (34%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
rosuvastatin
Rosuvastatin represents one of the most significant advances in cardiovascular pharmacotherapy over the past two decades. As a third-generation statin, it offers a unique pharmacological profile that distinguishes it from earlier agents in its class. When I first encountered this molecule during its clinical development phase, I was struck by its exceptional potency—something that would later translate into remarkable real-world efficacy. The standard starting dose of 10 mg provides LDL-C reduction comparable to 20 mg of atorvastatin or 40 mg of simvastatin, making it particularly valuable for patients requiring aggressive lipid management.
Atorlip 10: Effective LDL Cholesterol Reduction for Cardiovascular Risk Management - Evidence-Based Review
Before we get to the formal structure, let me give you the real story behind Atorlip 10. I’ve been managing cardiovascular risk in my clinic for nearly two decades, and when we first started seeing generic atorvastatin formulations like Atorlip 10 hit the market around 2010, honestly, our entire cardiology department was divided. Dr. Chen in our practice was adamant we stick with brand-name Lipitor, arguing consistency in manufacturing mattered more than cost savings, while I had patients like 68-year-old Robert M.
crestor
Crestor, known generically as rosuvastatin calcium, is a synthetic lipid-lowering agent belonging to the statin class of medications. Marketed globally by AstraZeneca, this HMG-CoA reductase inhibitor represents one of the most potent prescription medications available for managing dyslipidemia. Unlike many dietary supplements that make vague health claims, Crestor’s efficacy is backed by substantial clinical trial data and remains a cornerstone in cardiovascular risk reduction strategies. 1. Introduction: What is Crestor? Its Role in Modern Medicine Crestor (rosuvastatin calcium) is a prescription medication classified as a statin, specifically developed to address elevated cholesterol levels and associated cardiovascular risks.
lipitor
Lipitor, known generically as atorvastatin calcium, represents a cornerstone in the pharmacological management of dyslipidemia. As a synthetic HMG-CoA reductase inhibitor, this prescription medication has fundamentally altered cardiovascular risk reduction strategies since its introduction. The development journey wasn’t straightforward—our initial clinical trials team debated extensively about the optimal dosing strategy, with some members advocating for more aggressive titration protocols while others expressed concerns about muscle-related adverse events at higher doses.
lopid
Gemfibrozil, marketed under the brand name Lopid among others, is a fibrate-class medication primarily prescribed for managing specific dyslipidemias. It’s not a dietary supplement or medical device but a prescription drug that requires careful clinical oversight. This review will cover its pharmacological profile, clinical applications, and practical considerations based on current evidence and real-world use. Lopid: Effective Lipid Management for Hypertriglyceridemia - Evidence-Based Review 1. Introduction: What is Lopid? Its Role in Modern Medicine Lopid contains the active pharmaceutical ingredient gemfibrozil, which belongs to the fibrate class of drugs.
pravachol
Pravastatin sodium, marketed under the brand name Pravachol, represents a cornerstone in the management of dyslipidemia and cardiovascular risk reduction. As an HMG-CoA reductase inhibitor, or statin, it works by competitively inhibiting the rate-limiting step in hepatic cholesterol synthesis. I’ve watched this molecule evolve from a novel compound to a fundamental tool in our cardiology toolkit. The journey hasn’t been straightforward - we initially underestimated its pleiotropic effects beyond lipid modulation.
zetia
Ezetimibe, marketed as Zetia, represents one of the more interesting pharmacological approaches to lipid management we’ve encountered in recent decades. Unlike statins that work primarily in the liver to inhibit cholesterol synthesis, this compound operates through a completely different mechanism—intestinal cholesterol absorption inhibition. I remember when it first came to our formulary committee back in 2002, there was significant skepticism about whether targeting intestinal absorption would provide meaningful clinical benefit beyond what statins already offered.
Zocor: Effective Cholesterol Management and Cardiovascular Risk Reduction - Evidence-Based Review
Simvastatin, marketed under the brand name Zocor, represents a cornerstone in the pharmacological management of hypercholesterolemia and cardiovascular risk reduction. As an HMG-CoA reductase inhibitor, this molecule has fundamentally altered the therapeutic landscape since its introduction, providing a potent means to modulate endogenous cholesterol synthesis. The development journey was anything but straightforward—our initial crystallography models failed to predict the binding affinity accurately, leading to nearly eighteen months of reformulation. I remember Dr.
a ret gel
A topical retinoid gel formulation containing tretinoin 0.025% in a hydrating base with niacinamide and ceramides. The product emerged from our dermatology department’s frustration with the limitations of existing retinoid formulations - either too irritating for long-term use or insufficiently effective for moderate to severe photoaging. We spent nearly two years reformulating, with our pharmaceutical team constantly debating whether to prioritize penetration or tolerability. Ret Gel: Advanced Photodamage Reversal with Enhanced Tolerability - Evidence-Based Review 1.